Main Street Financial Solutions’s AstraZeneca AZN Stock Holding History

Main Street Financial Solutions’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$598K	Buy	3,152 +190	+6%	+$35.7K	0.04%	322
2026 Q1	$584K	Buy	2,962 +1,045	+55%	+$201K	0.04%	316
2025 Q4	$352K	Sell	1,917 -246	-11%	-$43.1K	0.03%	396
2025 Q3	$332K	Buy	+2,163	New	+$327K	0.02%	476
2024 Q4	–	Sell	-1,308	Closed	-$204K	–	491
2024 Q3	$204K	Sell	1,308 -151	-10%	-$24.4K	0.02%	504
2024 Q2	$227K	Buy	+1,459	New	+$220K	0.02%	483

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Main Street Financial Solutions's AZN Position: Q2 2026 in Review

Main Street Financial Solutions increased its AstraZeneca (AZN) stake by 6.4% in Q2 2026, buying an estimated $35.7K and bringing the position to 3,152 shares worth $598K. The position accounts for 0.04% of the portfolio, ranked #322.

Main Street Financial Solutions first reported a position in AZN in Q2 2024 and has held it in 6 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Main Street Financial Solutions held 3,152 shares of AstraZeneca worth $598K as of Q2 2026.
Main Street Financial Solutions bought 190 AstraZeneca shares in Q2 2026, an estimated $35.7K.
AstraZeneca made up 0.04% of Main Street Financial Solutions's portfolio in Q2 2026, its #322 holding.
Main Street Financial Solutions first reported a position in AstraZeneca in Q2 2024 and has held it in 6 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.